Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth.
Identifieur interne : 005630 ( Main/Exploration ); précédent : 005629; suivant : 005631Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth.
Auteurs : Alfonso Fasano [Italie] ; Francesco Bove ; Maurizio Gabrielli ; Enzo Ragazzoni ; Serena Fortuna ; Annalisa Tortora ; Maria Assunta Zocco ; Stefano Marconi ; Antonio Gasbarrini ; Anna Rita BentivoglioSource :
- Clinical neuropharmacology [ 1537-162X ]
English descriptors
- KwdEn :
- Aged, Analysis of Variance, Antiparkinson Agents, Breath Tests, Female, Gastrointestinal Agents (therapeutic use), Glucose (metabolism), Helicobacter Infections (diagnosis), Helicobacter Infections (drug therapy), Helicobacter Infections (epidemiology), Helicobacter pylori (pathogenicity), Humans, Lactulose (metabolism), Levodopa (analogs & derivatives), Levodopa (therapeutic use), Male, Middle Aged, Parkinson Disease (drug therapy), Parkinson Disease (epidemiology), Rifamycins (therapeutic use), Severity of Illness Index.
- MESH :
- chemical , analogs & derivatives : Levodopa.
- chemical , metabolism : Glucose, Lactulose.
- chemical , therapeutic use : Gastrointestinal Agents, Levodopa, Rifamycins.
- chemical : Antiparkinson Agents.
- diagnosis : Helicobacter Infections.
- drug therapy : Helicobacter Infections, Parkinson Disease.
- epidemiology : Helicobacter Infections, Parkinson Disease.
- pathogenicity : Helicobacter pylori.
- Aged, Analysis of Variance, Breath Tests, Female, Humans, Male, Middle Aged, Severity of Illness Index.
Abstract
Patients with Parkinson disease exhibit a highly increased prevalence of small intestinal bacterial overgrowth (SIBO), which has been also associated with the severity of motor fluctuations. Aim of this study was to test the efficacy of liquid levodopa with higher bioavailability in patients with SIBO.
DOI: 10.1097/WNF.0000000000000034
PubMed: 24992085
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000723
- to stream PubMed, to step Curation: 000723
- to stream PubMed, to step Checkpoint: 000723
- to stream Ncbi, to step Merge: 001817
- to stream Ncbi, to step Curation: 001817
- to stream Ncbi, to step Checkpoint: 001817
- to stream Main, to step Merge: 006047
- to stream Main, to step Curation: 005630
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth.</title><author><name sortKey="Fasano, Alfonso" sort="Fasano, Alfonso" uniqKey="Fasano A" first="Alfonso" last="Fasano">Alfonso Fasano</name><affiliation wicri:level="4"><nlm:affiliation>*Movement Disorders Center, TWH, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada; †Departments of Neurology, and ‡Internal Medicine, Catholic University of Sacred Heart, Gemelli University Hospital, Rome, Italy; §Department of Pharmacology, Catholic University of Sacred Heart, Rome, Italy; and ||Medical Direction, Chiesi Farmaceutici, Parma, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>*Movement Disorders Center, TWH, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada; †Departments of Neurology, and ‡Internal Medicine, Catholic University of Sacred Heart, Gemelli University Hospital, Rome, Italy; §Department of Pharmacology, Catholic University of Sacred Heart, Rome, Italy; and ||Medical Direction, Chiesi Farmaceutici, Parma</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Bove, Francesco" sort="Bove, Francesco" uniqKey="Bove F" first="Francesco" last="Bove">Francesco Bove</name></author><author><name sortKey="Gabrielli, Maurizio" sort="Gabrielli, Maurizio" uniqKey="Gabrielli M" first="Maurizio" last="Gabrielli">Maurizio Gabrielli</name></author><author><name sortKey="Ragazzoni, Enzo" sort="Ragazzoni, Enzo" uniqKey="Ragazzoni E" first="Enzo" last="Ragazzoni">Enzo Ragazzoni</name></author><author><name sortKey="Fortuna, Serena" sort="Fortuna, Serena" uniqKey="Fortuna S" first="Serena" last="Fortuna">Serena Fortuna</name></author><author><name sortKey="Tortora, Annalisa" sort="Tortora, Annalisa" uniqKey="Tortora A" first="Annalisa" last="Tortora">Annalisa Tortora</name></author><author><name sortKey="Zocco, Maria Assunta" sort="Zocco, Maria Assunta" uniqKey="Zocco M" first="Maria Assunta" last="Zocco">Maria Assunta Zocco</name></author><author><name sortKey="Marconi, Stefano" sort="Marconi, Stefano" uniqKey="Marconi S" first="Stefano" last="Marconi">Stefano Marconi</name></author><author><name sortKey="Gasbarrini, Antonio" sort="Gasbarrini, Antonio" uniqKey="Gasbarrini A" first="Antonio" last="Gasbarrini">Antonio Gasbarrini</name></author><author><name sortKey="Bentivoglio, Anna Rita" sort="Bentivoglio, Anna Rita" uniqKey="Bentivoglio A" first="Anna Rita" last="Bentivoglio">Anna Rita Bentivoglio</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="????"><PubDate><MedlineDate>2014 Jul-Aug</MedlineDate></PubDate></date><idno type="RBID">pubmed:24992085</idno><idno type="pmid">24992085</idno><idno type="doi">10.1097/WNF.0000000000000034</idno><idno type="wicri:Area/PubMed/Corpus">000723</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000723</idno><idno type="wicri:Area/PubMed/Curation">000723</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000723</idno><idno type="wicri:Area/PubMed/Checkpoint">000723</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000723</idno><idno type="wicri:Area/Ncbi/Merge">001817</idno><idno type="wicri:Area/Ncbi/Curation">001817</idno><idno type="wicri:Area/Ncbi/Checkpoint">001817</idno><idno type="wicri:Area/Main/Merge">006047</idno><idno type="wicri:Area/Main/Curation">005630</idno><idno type="wicri:Area/Main/Exploration">005630</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth.</title><author><name sortKey="Fasano, Alfonso" sort="Fasano, Alfonso" uniqKey="Fasano A" first="Alfonso" last="Fasano">Alfonso Fasano</name><affiliation wicri:level="4"><nlm:affiliation>*Movement Disorders Center, TWH, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada; †Departments of Neurology, and ‡Internal Medicine, Catholic University of Sacred Heart, Gemelli University Hospital, Rome, Italy; §Department of Pharmacology, Catholic University of Sacred Heart, Rome, Italy; and ||Medical Direction, Chiesi Farmaceutici, Parma, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>*Movement Disorders Center, TWH, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada; †Departments of Neurology, and ‡Internal Medicine, Catholic University of Sacred Heart, Gemelli University Hospital, Rome, Italy; §Department of Pharmacology, Catholic University of Sacred Heart, Rome, Italy; and ||Medical Direction, Chiesi Farmaceutici, Parma</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Bove, Francesco" sort="Bove, Francesco" uniqKey="Bove F" first="Francesco" last="Bove">Francesco Bove</name></author><author><name sortKey="Gabrielli, Maurizio" sort="Gabrielli, Maurizio" uniqKey="Gabrielli M" first="Maurizio" last="Gabrielli">Maurizio Gabrielli</name></author><author><name sortKey="Ragazzoni, Enzo" sort="Ragazzoni, Enzo" uniqKey="Ragazzoni E" first="Enzo" last="Ragazzoni">Enzo Ragazzoni</name></author><author><name sortKey="Fortuna, Serena" sort="Fortuna, Serena" uniqKey="Fortuna S" first="Serena" last="Fortuna">Serena Fortuna</name></author><author><name sortKey="Tortora, Annalisa" sort="Tortora, Annalisa" uniqKey="Tortora A" first="Annalisa" last="Tortora">Annalisa Tortora</name></author><author><name sortKey="Zocco, Maria Assunta" sort="Zocco, Maria Assunta" uniqKey="Zocco M" first="Maria Assunta" last="Zocco">Maria Assunta Zocco</name></author><author><name sortKey="Marconi, Stefano" sort="Marconi, Stefano" uniqKey="Marconi S" first="Stefano" last="Marconi">Stefano Marconi</name></author><author><name sortKey="Gasbarrini, Antonio" sort="Gasbarrini, Antonio" uniqKey="Gasbarrini A" first="Antonio" last="Gasbarrini">Antonio Gasbarrini</name></author><author><name sortKey="Bentivoglio, Anna Rita" sort="Bentivoglio, Anna Rita" uniqKey="Bentivoglio A" first="Anna Rita" last="Bentivoglio">Anna Rita Bentivoglio</name></author></analytic><series><title level="j">Clinical neuropharmacology</title><idno type="eISSN">1537-162X</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Analysis of Variance</term><term>Antiparkinson Agents</term><term>Breath Tests</term><term>Female</term><term>Gastrointestinal Agents (therapeutic use)</term><term>Glucose (metabolism)</term><term>Helicobacter Infections (diagnosis)</term><term>Helicobacter Infections (drug therapy)</term><term>Helicobacter Infections (epidemiology)</term><term>Helicobacter pylori (pathogenicity)</term><term>Humans</term><term>Lactulose (metabolism)</term><term>Levodopa (analogs & derivatives)</term><term>Levodopa (therapeutic use)</term><term>Male</term><term>Middle Aged</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson Disease (epidemiology)</term><term>Rifamycins (therapeutic use)</term><term>Severity of Illness Index</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Levodopa</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Glucose</term><term>Lactulose</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Gastrointestinal Agents</term><term>Levodopa</term><term>Rifamycins</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Antiparkinson Agents</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Helicobacter Infections</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Helicobacter Infections</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Helicobacter Infections</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Helicobacter pylori</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Analysis of Variance</term><term>Breath Tests</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Severity of Illness Index</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Patients with Parkinson disease exhibit a highly increased prevalence of small intestinal bacterial overgrowth (SIBO), which has been also associated with the severity of motor fluctuations. Aim of this study was to test the efficacy of liquid levodopa with higher bioavailability in patients with SIBO.</div></front></TEI><affiliations><list><country><li>Italie</li></country><region><li>Ontario</li></region><settlement><li>Toronto</li></settlement><orgName><li>Université de Toronto</li></orgName></list><tree><noCountry><name sortKey="Bentivoglio, Anna Rita" sort="Bentivoglio, Anna Rita" uniqKey="Bentivoglio A" first="Anna Rita" last="Bentivoglio">Anna Rita Bentivoglio</name><name sortKey="Bove, Francesco" sort="Bove, Francesco" uniqKey="Bove F" first="Francesco" last="Bove">Francesco Bove</name><name sortKey="Fortuna, Serena" sort="Fortuna, Serena" uniqKey="Fortuna S" first="Serena" last="Fortuna">Serena Fortuna</name><name sortKey="Gabrielli, Maurizio" sort="Gabrielli, Maurizio" uniqKey="Gabrielli M" first="Maurizio" last="Gabrielli">Maurizio Gabrielli</name><name sortKey="Gasbarrini, Antonio" sort="Gasbarrini, Antonio" uniqKey="Gasbarrini A" first="Antonio" last="Gasbarrini">Antonio Gasbarrini</name><name sortKey="Marconi, Stefano" sort="Marconi, Stefano" uniqKey="Marconi S" first="Stefano" last="Marconi">Stefano Marconi</name><name sortKey="Ragazzoni, Enzo" sort="Ragazzoni, Enzo" uniqKey="Ragazzoni E" first="Enzo" last="Ragazzoni">Enzo Ragazzoni</name><name sortKey="Tortora, Annalisa" sort="Tortora, Annalisa" uniqKey="Tortora A" first="Annalisa" last="Tortora">Annalisa Tortora</name><name sortKey="Zocco, Maria Assunta" sort="Zocco, Maria Assunta" uniqKey="Zocco M" first="Maria Assunta" last="Zocco">Maria Assunta Zocco</name></noCountry><country name="Italie"><region name="Ontario"><name sortKey="Fasano, Alfonso" sort="Fasano, Alfonso" uniqKey="Fasano A" first="Alfonso" last="Fasano">Alfonso Fasano</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005630 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005630 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:24992085
|texte= Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24992085" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |